If you liked this article you might like

Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment
Cramer: 3 Health Care Bill Scenarios, 3 Game Plans
Can Abbott Outperform Despite Alere?
Consumers Are Spending in Plain Sight: Cramer's 'Mad Money' Recap (Thursday 3/16/17)